Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$1.33 - $1.77 $59,451 - $79,119
-44,700 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$1.41 - $1.94 $42,723 - $58,782
-30,300 Reduced 40.4%
44,700 $64,000
Q1 2021

May 17, 2021

BUY
$1.61 - $2.77 $85,813 - $147,641
53,300 Added 245.62%
75,000 $135,000
Q4 2020

Feb 16, 2021

SELL
$1.55 - $2.24 $1.4 Million - $2.02 Million
-900,537 Reduced 97.65%
21,700 $38,000
Q3 2020

Nov 16, 2020

BUY
$1.91 - $3.08 $1.76 Million - $2.84 Million
922,237 New
922,237 $1.8 Million
Q1 2020

May 15, 2020

SELL
$1.17 - $3.0 $58,407 - $149,763
-49,921 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.16 - $1.42 $57,908 - $70,887
49,921 New
49,921 $61,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.65 $155,167 - $211,592
-128,238 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$1.39 - $2.03 $89,215 - $130,293
-64,184 Reduced 33.36%
128,238 $215,000
Q1 2019

May 15, 2019

BUY
$1.39 - $1.71 $165,013 - $203,002
118,715 Added 161.06%
192,422 $289,000
Q4 2018

Feb 14, 2019

SELL
$1.41 - $2.16 $79,392 - $121,623
-56,307 Reduced 43.31%
73,707 $106,000
Q3 2018

Nov 14, 2018

BUY
$1.86 - $2.18 $241,826 - $283,430
130,014 New
130,014 $273,000
Q2 2018

Aug 14, 2018

BUY
$1.76 - $2.79 $42,192 - $66,884
23,973 New
23,973 $47,000
Q1 2018

May 15, 2018

SELL
$1.34 - $2.03 $105,641 - $160,039
-78,837 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$1.65 - $2.45 $187,378 - $278,229
-113,563 Reduced 59.02%
78,837 $143,000
Q3 2017

Nov 14, 2017

BUY
$1.5 - $2.55 $288,600 - $490,619
192,400
192,400 $396,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.